Dear contact name,

RNAseq is powerful but, for some scientists, is a source of delays and added cost due to limited sequencing or data analysis capacity.

It’s not just about investment. One pharma company built a $10 million RNAseq pipeline but still had a 30 day waiting time for results.

By using other transcriptomic methods when appropriate, other pharma programs get their results faster and reduce the pressure on RNAseq resources.

If whole-transcriptome lncRNA and mRNA analysis in 3 days was possible, how would you use it? Especially if 10 minutes, with complimentary software, gave you insights into high and low expressed genes, exons and transcript isoforms.